Related Experiment Video
Updated: Mar 16, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell
Takuma Higuchi1, Hiroshi Todaka1, Yasunori Sugiyama1
1From the Laboratory of Molecular Biology, Science Research Center.
Abstract:
MicroRNA-7 (miR-7)has been characterized as an anti-oncogenic microRNA (miRNA) in several cancers, including hepatocellular carcinoma (HCC). However, the mechanism for the regulation of miR-7 production in tumors remains unclear. Here, we identified nuclear factor 90 (NF90) and NF45 complex (NF90-NF45) as negative regulators of miR-7 processing in HCC. Expression of NF90 and NF45 was significantly elevated in primary HCC tissues compared with adjacent non-tumor tissues. To examine which miRNAs are controlled by NF90-NF45, we performed an miRNA microarray and quantitative RT-PCR analyses of HCC cell lines. Depletion of NF90 resulted in elevated levels of mature miR-7, whereas the expression of primary miR-7-1 (pri-miR-7-1) was decreased in cells following knockdown of NF90. Conversely, the levels of mature miR-7 were reduced in cells overexpressing NF90 and NF45, although pri-miR-7-1 was accumulated in the same cells. Furthermore, NF90-NF45 was found to bind pri-miR-7-1 in vitro These results suggest that NF90-NF45 inhibits the pri-miR-7-1 processing step through the binding of NF90-NF45 to pri-miR-7-1. We also found that levels of the EGF receptor, an oncogenic factor that is a direct target of miR-7, and phosphorylation of AKT were significantly decreased in HCC cell lines depleted of NF90 or NF45. Of note, knockdown of NF90 or NF45 caused a reduction in the proliferation rate of HCC cells. Taken together, NF90-NF45 stimulates an elevation of EGF receptor levels via the suppression of miR-7 biogenesis, resulting in the promotion of cell proliferation in HCC.
Insights
Nuclear factor 90 (NF90) and NF45 complex (NF90-NF45) inhibit microRNA-7 (miR-7) processing in hepatocellular carcinoma (HCC). This leads to increased EGF receptor levels and promotes HCC cell proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNA-7 (miR-7) functions as an anti-oncogenic microRNA (miRNA) in various cancers, including hepatocellular carcinoma (HCC).
- The precise mechanisms regulating miR-7 production within tumor cells are not fully understood.
Purpose of the Study:
- To identify novel regulators of miR-7 processing in HCC.
- To elucidate the role of the nuclear factor 90 (NF90) and NF45 complex (NF90-NF45) in miR-7 biogenesis and HCC progression.
Main Methods:
- miRNA microarray and quantitative RT-PCR analyses were performed on HCC cell lines.
- NF90 and NF45 expression levels were assessed in HCC tissues.
- In vitro binding assays were conducted to evaluate the interaction between NF90-NF45 and pri-miR-7-1.
Main Results:
- NF90-NF45 complex was identified as a negative regulator of miR-7 processing in HCC.
- Depletion of NF90 or NF45 elevated mature miR-7 levels and reduced primary miR-7-1 (pri-miR-7-1) expression.
- NF90-NF45 directly binds to pri-miR-7-1, inhibiting its processing.
- NF90-NF45 knockdown decreased EGF receptor levels and AKT phosphorylation, inhibiting HCC cell proliferation.
Conclusions:
- NF90-NF45 suppresses miR-7 biogenesis by inhibiting pri-miR-7-1 processing.
- This suppression leads to elevated EGF receptor levels, promoting HCC cell proliferation.
- Targeting the NF90-NF45 complex may offer a therapeutic strategy for HCC.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Co-activators and Co-repressors

